Publications by authors named "Jon Rasmussen"

Claim this Profile
C
Characterization of Leydig Cell Dysfunction in Previous Illicit Androgen Users.
Yeliz Bulut, Niels Brandt-Jacobsen, Rasmus Madsen, Mario Thevis, Jan Frystyk, Jon Jarløv Rasmussen

J Clin Endocrinol Metab· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central Nervous System Polypharmacy Among People Living With Dementia.
Elizabeth A Bayliss, J David Powers, Linda A Weffald, Jon R Rasmussen, Lisa E Pieper

J Am Med Dir Assoc· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Illicit Anabolic Steroid Use and Cardiovascular Status in Men and Women.
Laust Frisenberg Buhl, Louise Lehmann Christensen, Rikke Hjortebjerg, Selma Hasific, Clara Hjerrild, Jon Jarløv Rasmussen

JAMA Netw Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reevaluating Growth Hormone Therapy in HFrEF: More Questions Than Answers?
Finn Gustafsson, Caroline Kistorp, Jon Jarløv Rasmussen

JACC Heart Fail· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of letrozole therapy in former users of anabolic steroids: A randomized clinical trial.
Jon Jarløv Rasmussen, Yeliz Bulut, Niels Brandt-Jacobsen, Jan Frystyk, Jakob Albrethsen

J Intern Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Letter to the Editor From van Os et al: "Persistently Decreased Quality of Life and its Determinants in Previous Illicit Androgen Users".
Yeliz Bulut, Caroline Kistorp, Jon Jarløv Rasmussen

J Clin Endocrinol Metab· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary Microvascular Dysfunction Years After Cessation of Anabolic Androgenic Steroid Use.
Yeliz Bulut, Jon Jarløv Rasmussen, Niels Brandt-Jacobsen, Jan Frystyk, Mario Thevis

JAMA Netw Open· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brønsted Acid-Lewis Acid (BA-LA) Induced Final Deprotection/Peptide Resin Cleavage in Fmoc/Bu Solid-Phase Peptide Synthesis: HCl/FeCl and AcOH/FeCl as Viable PFAS-Free Alternatives for TFA.
Jan Pawlas, Christophe André, Jon H Rasmussen, Olivier Ludemann-Hombourger

Org Lett· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistently Decreased Quality of Life and its Determinants in Previous Illicit Androgen Users.
Yeliz Bulut, Niels Brandt-Jacobsen, Laust Buhl, Morten Schou, Jan Frystyk, Jon Jarløv Rasmussen

J Clin Endocrinol Metab· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher Myonuclei Density in Muscle Fibers Persists Among Former Users of Anabolic Androgenic Steroids.
Jakob Lindberg Nielsen, Jon Jarløv Rasmussen, Mikkel Nicklas Frandsen, Jeppe Fredberg, Niels Høegh Brandt-Jacobsen

J Clin Endocrinol Metab· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of cardiac adipose tissue volume with short-term empagliflozin treatment in patients with type 2 diabetes: A substudy from the SIMPLE randomized clinical trial.
Niels H Brandt-Jacobsen, Mikkel Jürgens, Philip Hasbak, Peter Gaede, Peter Rossing, Jon J Rasmussen

Diabetes Obes Metab· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect on cardiac function among patients with type 2 diabetes following high-dose mineralocorticoid receptor antagonist using echocardiography; data from the MIRAD randomized clinical trial.
Niels H Brandt-Jacobsen, Marie Louise Johansen, Jon J Rasmussen, Morten Dalsgaard, Thomas Kumler

BMC Cardiovasc Disord· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Emancipatory Design Manifesto: Let's Suppose That Disability Does Not Exist.
Jon Dag Rasmussen, Anne Britt Torkildsby

Stud Health Technol Inform· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Environmentally Sensible Organocatalytic Fmoc/-Bu Solid-Phase Peptide Synthesis.
Jan Pawlas, Jon H Rasmussen

Org Lett· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic steatosis is associated with anthropometry, cardio-metabolic disease risk, sex, age and urbanisation, but not with ethnicity in adult Kenyans.
Sophie E Kastberg, Helene S Lund, Emanuella De Lucia-Rolfe, Lydia U Kaduka, Michael K Boit, Jon J Rasmussen

Trop Med Int Health· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Anabolic-Androgenic Steroid Abuse on the Contact Activation System.
Johannes Jakobsen Sidelmann, Jørgen Brodersen Gram, Yaseelan Palarasah, Jon Jarløv Rasmussen, Caroline Kistorp

Thromb Haemost· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparable Outcomes of Short-Course and Prolonged-Course Therapy in Selected Cases of Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Pooled Cohort Study.
Louise Thorlacius-Ussing, Håkon Sandholdt, Jette Nissen, Jon Rasmussen, Robert Skov

Clin Infect Dis· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circular Aqueous Fmoc/t-Bu Solid-Phase Peptide Synthesis.
Jan Pawlas, Jon H Rasmussen

ChemSusChem· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mineralocorticoid Receptor Antagonist Improves Cardiac Structure in Type 2 Diabetes: Data From the MIRAD Trial.
Niels H Brandt-Jacobsen, Per Lav Madsen, Marie Louise Johansen, Jon J Rasmussen, Julie L Forman

JACC Heart Fail· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of high-dose mineralocorticoid receptor antagonist eplerenone on urinary albumin excretion in patients with type 2 diabetes and high cardiovascular risk: Data from the MIRAD trial.
Niels H Brandt-Jacobsen, Marie Louise Johansen, Jon Rasmussen, Julie L Forman, Maria Refsgaard Holm

Diabetes Metab· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Abductive Inference Approach to Assess the Performance-Enhancing Effects of Drugs Included on the World Anti-Doping Agency Prohibited List.
Andreas Breenfeldt Andersen, Glenn A Jacobson, Jacob Bejder, Dino Premilovac, Stephen M Richards, Jon J Rasmussen

Sports Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Insulin-like Factor 3 Levels Are Reduced in Former Androgen Users, Suggesting Impaired Leydig Cell Capacity.
Jon Jarløv Rasmussen, Jakob Albrethsen, Mikkel Nicklas Frandsen, Niels Jørgensen, Anders Juul

J Clin Endocrinol Metab· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anabolic-Androgenic Steroid Abuse Impairs Fibrin Clot Lysis.
Johannes Jakobsen Sidelmann, Jørgen Brodersen Gram, Jon J Rasmussen, Caroline Kistorp

Semin Thromb Hemost· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Mineralocorticoid Receptor Antagonist Eplerenone Suppresses Interstitial Fibrosis in Subcutaneous Adipose Tissue in Patients With Type 2 Diabetes.
Marie Louise Johansen, Jaime Ibarrola, Amaya Fernández-Celis, Morten Schou, Mette Pauli Sonne, Jon Rasmussen

Diabetes· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of the glucagon-like peptide-1 receptor agonist liraglutide on natriuretic peptides in heart failure patients with reduced ejection fraction with and without type 2 diabetes.
Roni Nielsen, Anders Jorsal, Rasmus S Tougaard, Jon J Rasmussen, Morten Schou

Diabetes Obes Metab· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis